Investors Contact Careers

Interpace Biosciences, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
  • Diagnostics
  • Pharma Solutions
    • Overview
    • Biomarkers Solutions
    • Genomics Services/Molecular Dx
    • Anatomic Path, Flow, and Cytogenetics
    • Integrated Biorepository
    • Bioinformatics Solutions
  • Patients
  • Labs
  • News & Media
    • Press Releases
    • In The News
    • Presentations
    • Events
  • Investors
  • Contact
  • Careers

Press Releases

News & Media

News & Media

  • Press Releases
  • In The News
  • Presentations
  • Events

Interpace Diagnostics to Host Conference Call and Webcast to Discuss Second Quarter 2018 Financial Results on Thursday, August 9, 2018

Aug 1, 2018

Interpace Diagnostics Regains Compliance with NASDAQ Minimum Bid Price Listing Requirement

Jul 31, 2018

Interpace Diagnostics Announces CIGNA’s Expansion of Coverage to Now Include ThyraMIR®

Jul 26, 2018

Interpace Diagnostics Expands Application of Pancreatic Cancer Test

Jul 19, 2018

Interpace Diagnostics Announces Coverage of Thyroid Testing by Blue Cross Blue Shield of Florida

Jun 11, 2018

Interpace Diagnostics to Attend and Present at the 8th Annual LD Micro Invitational Conference

Jun 4, 2018

Interpace Diagnostics Presents New Data on PancraGEN® at Digestive Disease Week

Jun 1, 2018

Interpace Diagnostics Enters into Agreement with Nationally Renowned Institution

May 30, 2018

Interpace Diagnostics Group Reports First Quarter 2018 Financial Results, Business Progress and Recent Accomplishments

May 15, 2018

Interpace Diagnostics Announces Launch of New Thyroid Test

May 14, 2018
    • 1...
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • ...17
    © 2019 Interpace Biosciences, Inc. All Rights Reserved.
    Privacy Policy HIPAA Privacy Disclaimer Sitemap
    • Twitter
    • Facebook
    • Linkedin